Wesson J, Gmach R, Gazi R, et al. Provider views on the acceptability of an IUD checklist screening tool. Contraception 2006;74(5):382-8.
Usinger KM, Gola SB, Weis M, Smaldone A. Intrauterine Contraception Continuation in Adolescents and Young Women : A Systematic Review. J Peiatr Adolesc Gynecol 2016 ;29(6) :659-667.
United Nations (UN). World Contraceptive Use 2018. New York: UN, Department of Economic and Social Affairs, Population Division, 2018.
Trussell J. Contraceptive failure in the United States. Contraception 2011;83:397-404.
Tepper NK, Steenland MW, Gaffield ME, Marchbanks PA, Curtis KM. Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review. Contraception 2013;87(5):655-60.
Tepper NK, Steenland MW, Marchbanks PA, Curtis KM et al. Hemoglobin measurement prior to initiating copper intrauterine devices: a systematic review. Contraception 2013;87(5):639-44.
Tepper NK, Curtis KM, Nanda K, Jamieson DJ. Safety of intrauterine devices among women with HIV: a systematic review. Contraception 2016;94(6):713-724.
Stringer EM, Kaseba C, Levy J, et al. A randomized trial of the intrauterine contraceptive device vs. hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Ob Gyn August 2007; 197(2): 144: e2 – e8.
Steenland MW, Lauren B, Zapata LB, Brahmi D, Marchbanks PA, Curtis KM. The effect of follow-up visits or contacts after contraceptive initiation on method continuation and correct use. Contraception 2013;87(5):626-30.
Stanback J , Shelton JD. Pelvic inflammatory disease attributable to the IUD: modeling risk in West Africa. Contraception 2008;77(4):227–9.
Solter C. Intrauterine Devices (IUDs): Participant’s Manual. Watertown, MA: Pathfinder International, 2008.
Sivin I, Greenslade F, Schmidt F, et al. The Copper T 380 Intrauterine Device: A Summary of Scientific Data. New York: The Population Council, 1992.
Sivin I. Dose and age dependent ectopic pregnancy risks with intrauterine contraception. Obstet Gynecol, 1991;78(2):291-8.
Sivin I. Alternative estimates of ectopic pregnancy risks during contraception. Am J Obstet Gynecol. 1991;165(6 Pt 1):1900.
Shelton J. Risk of clinical pelvic inflammatory disease attributable to an intrauterine device. Lancet 2001;357(9253):443.
Salem R. New Attention to the IUD: Expanding Women’s Contraceptive Options To Meet Their Needs. Population Reports, Series B, No. 7. Baltimore: Johns Hopkins Bloomberg School of Public Health, Center for Communications Programs, The INFO Project, 200
Richardson BA, Morrison CS, Sekadde-Kigondu C, et al. Effect of intrauterine device on cervical shedding of HIV-1 DNA. AIDS 1999;13(15):2091-97.
Phillips SJ, Curtis KM, Polis CB. Effect of hormonal contraceptive methods on HIV disease progression: a systematic review. AIDS 2013;27(5):787-94.
Ortiz ME, Croxatto HB. Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action. Contraception 2007 Jun;75(6 Suppl):S16-30.
O’Hanley K, Huber DH. Postpartum IUDs: keys for success. Contraception 1992;45(4):351-61.
Mueller MP, Lasway C, Yacobson I, Tumlinson K. Training and Reference Guide for a Screening Checklist to Initiate Use of the Copper IUD. Research Triangle Park, NC: Family Health International, 2008.
Larsson C, Milsom I, Jonasson K, et al. The long-term effects of copper surface area on menstrual blood loss and iron status in women fitted with an IUD. Contraception 1993;48(5):471-80.
Kulier R, Helmerhorst FM, O’Brien P, et al. Copper containing, framed intra-uterine devices for contraception. Cochrane Database Syst Rev 2006;3:CD005347.
Heikinheimo O, Lahteenmaki P. Contraception and HIV infection in women. Hum Reprod Update. 2009 Mar-Apr;15(2):165-76.
Hubacher D. Copper intrauterine device use by nulliparous women: review of side effects. Contraception 2007;75: S8–S11.
Hubacher, D. et al. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. New England Journal of Medicine 2001;345(8):561-567.
Grimes D, Lopez LM, Schulz K, et al. Immediate post-partum insertion of intrauterine devices. Cochrane Database Syst Rev. 2010 May 12;(5):CD003036.
Godfrey EM, Whiteman MK, Curtis KM. Treatment of bleeding irregularities in women with copper-containing IUDs : a systematic review. Contraception 2013 ;87(5) :549-66.
Farr G, Amatya R. Contraceptive efficacy of the copper T380A and the multiload Cu250 IUD in three developing countries. Adv Contracept 1994;10:137-49.
Farley TM, Rosenberg MJ, Rowe PJ, et al. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet. 1992 Mar 28;339(8796):785-788.
Deans EI, Grimes DA. Intrauterine devices for adolescents: a systematic review. Contraception. 2009 Jun;79(6):418-23.
DeMaeyer EM, Dallman P, Gurney JM, et al. Preventing and Controlling Iron Deficiency Anaemia through Primary Health Care. A Guide for Health Administrators and Programme Managers. Geneva: World Health Organization, 1989.
Colwill AC, Schrieber CA, Sammel MD, Sonalkar S. Six-week retention after postplacental copper intrauterine device placement. Contraception 201897(3):215-218.
Chi IC, Wilkens L, Rogers S. Expulsions in immediate postpartum insertion of Lippes Loop D and copper T IUDs and their counterpart delta devices: An epidemiological analysis. Contraception, 1985; 32(2):119-134
Carr SL, Singh RH, Sussman AL, Rogers RG, Preda B, Espey E. Women’s experiences with immediate postpartum intrauterine device insertion: a mixed-methods study. Contraception 2018;97(3):219-226
Brahmi D, Steenland MW, Renner RM, Gaffield ME, Curtis KM. Pregnancy outcomes with an IUD in situ: a systematic review. Contraception 2012;85(2): 131-9.
Browne H, Manipalviratn S, Armstrong A. Using an intrauterine device in immunocompromised women. Obstet Gynecol 2008;112:667–9.
Bluestone J, Chase R, Lu ER. IUD Guidelines for Family Planning Service Programs: A Problem-Solving Reference Manual. Baltimore, MD: Jhpiego, 2006.
Anteby E, Revel A, Ben-Chetrit A, et al. Intrauterine device failure: relation to its location within the uterine cavity. Obstet Gynecol 1993;81(1):112-114
TCu380A Intrauterine Contraceptive Device (IUD): Specification, Prequalification and Guidelines for Procurement, 2010. WHO
The Postpartum Intrauterine Device: A Training Course for Service Providers, Trainer’s Manual (EngenderHealth/The ACQUIRE Project, 2008)
Global Postpartum Intrauterine Contraceptive Device (PPIUCD) Learning Resource Package (LRP) (Jhpiego/ACCESS FP, 2010. Includes reference manual, trainers guide and learners guide.)
Intrauterine Devices (IUDs), Second Edition (Pathfinder International, 2008.)
Participant’s Guide
Intrauterine Devices (IUDs), Second Edition (Pathfinder International, 2008.)
Trainer’s Guide
IUD Guidelines for Family Planning Service Programs: A Problem-Solving Reference Manual (Jhpiego, 2006)
Knowledge for Health, IUD Toolkit
The WHO Medical Eligibility Criteria Wheel for Contraceptive Use (2015)
A tool that makes it easy to identify medical eligibility for use of family planning methods.
The Selected Practice Recommendations for Contraceptive Use (3rd Edition 2016).
This resource provides guidance on how to use contraceptive methods safely and effectively, once they are deemed to be medically appropriate.
The Medical Eligibility Criteria for Contraceptive Use (5th edition 2015
This resource provides guidance on whether people with certain medical conditions can safely and effectively use specific contraceptive methods.
Family Planning: A Global Handbook for Providers (2022 update).
This book serves as a quick-reference resource for all level of health care workers. It provides practical guidance on delivering family planning methods appropriately and effectively.
